3 Wishes Project for End-of-Life Care
(WISHES Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve the end-of-life experience for patients in safety-net hospitals, which often have fewer resources and serve diverse, disadvantaged populations. It seeks to achieve this by implementing the 3 Wishes Project, a program that honors the final wishes of patients dying in intensive care units (ICUs). The goal is to provide compassionate care that makes the process more meaningful for both patients and their families. Families of patients in the ICU, where a decision has been made to withdraw life support or where the patient is not expected to survive the hospital stay, would be a good fit for this trial. Participants should be able to communicate in English or Spanish. As an unphased trial, this study offers a unique opportunity to contribute to compassionate care practices that can enhance the dignity and comfort of patients and their families.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the 3 Wishes Project is safe for end-of-life care?
Research has shown that the 3 Wishes Project is well-received and safe. In one study, 99.2% of final wishes were granted for 101 patients nearing the end of life. This project emphasizes making patients' last moments meaningful, rather than focusing on medical treatments. Another study examined the project's impact on families and found positive experiences in intensive care units. The project offers a low-cost method to provide compassionate care. Overall, evidence suggests that the 3 Wishes Project is a safe and meaningful way to support patients and families during end-of-life care.12345
Why are researchers excited about this trial?
Researchers are excited about the 3 Wishes Project for end-of-life care because it offers a compassionate approach that focuses on fulfilling the dying wishes of patients in the ICU. Unlike traditional medical treatments that primarily aim to extend life or manage symptoms, this project enhances the quality of end-of-life experiences by personalizing care and creating meaningful memories for both patients and their families. This approach can provide emotional support and closure, making it a unique and potentially transformative addition to end-of-life care practices.
What evidence suggests that the 3 Wishes Project is effective for improving end-of-life care?
Research shows that the 3 Wishes Project (3WP), studied in this trial, makes end-of-life experiences more personal and caring. Studies have found that 3WP honors patients' final wishes, making the process more dignified and comfortable for both patients and their families. For instance, one study found that families coped better with loss when they celebrated a patient’s life through this program. The project also builds strong connections among patients, families, and healthcare providers by using palliative care practices, which focus on comfort and support for those who are dying. By emphasizing these personal touches, the 3WP may improve the overall experience during a difficult time.12467
Are You a Good Fit for This Trial?
This trial is for patients at the end of their life in safety-net hospitals, which often serve diverse and disadvantaged populations. The goal is to improve the quality of end-of-life care by honoring final wishes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of the 3 Wishes Project in safety-net hospitals to improve end-of-life care
Evaluation
Evaluation of the quality of end-of-life ICU care, bereaved families' psychological symptoms, and clinician burnout
Follow-up
Monitoring of nurse burnout and effectiveness of the 3 Wishes Project
What Are the Treatments Tested in This Trial?
Interventions
- 3 Wishes Project
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
LAC+USC Medical Center
Collaborator
Olive View-UCLA Education & Research Institute
Collaborator
National Institute of Nursing Research (NINR)
Collaborator